louisiana glp-1 gastric stasis lawsuit Trulicity [2026] Will Louisiana Blue Pay for

Cardiometabolic Health:Can improve cholesterol levels, lower blood pressure, and reduce risk factors for heart disease

This is the first retrospective trial to evaluate the clinical impact of GLP-1 RAs for patients withmoderate PAD

Image Credit: Visual Capitalist Data: S&P global, GLP-1 Men, Financial times, IFEBP & Reuters #biotech #biopharma #GLP1 #obesity | 14 comments on LinkedIn

GLP-1 medications like Wegovy, Zepbound, and compounded alternatives are increasingly being used to lose the last 5 to 10 pounds. But is that goal worth the long-term commitment these medications often require

And honestly? Thats exactly how it feels